neurocare and MAG & More are very pleased to announce the integration of MAG & More into theneurocare group. MAG & More is a German based leader in the field of repetitive transcranialmagnetic stimulation (rTMS) improving the quality of living for people suffering from depression.rTMS assisted therapy is evidence based and reimbursed in a growing number of countries, such asthe US, Japan, Australia and European key markets. As well as depression, rTMS is applied for anincreasing number of clinical indications such as obsessive compulsive disorders and pain. “This is akey step in strengthening neurocare’s leading Digital Therapeutics (DTx) platform and MAG & More’sgeographical coverage is an excellent complement to our own global footprint” said AlexanderZobel, COO Digital Therapeutics and Group CFO at neurocare.
By joining forces, both neurocare and MAG & More will be stronger and more innovative.
KerstinHäringer, Founder and CEO of MAG & More, is excited about the common future: “I truly believe thatneurocare and MAG & More make a perfect match and I am much looking forward to shape thefuture in mental health on a larger scale. neurocare’s holistic approach and their DTx platformenable therapists to deliver best practice by personalizing therapy including the use of rTMS.”
Tom Mechtersheimer, Founder and CEO of neurocare, said: ”We warmly welcome Kerstin and herteam with their proud history of developing and marketing high quality technology. We are lookingforward to driving future innovations such as integrating our novel neurocardiac-guided navigationsystem for rTMS within our DTx platform”.
neurocare is innovating mental health and performance and developed a digital therapeutics (DTx) platform empowering clinicians to deliver best practice. Following a detailed assessment, clinicians develop personalised therapy plans that lead to best evidence-based outcomes. neurocare’s objective and measurable approach is based on our brain’s natural ability to learn (neuroplasticity) adding technology to enhance that learning and the care delivery. Since this approach enables individuals to regain their selfregulation it is a sustainable solution with very few side effects and significantly more than symptom management.
About MAG & More
MAG & More is a medical device company, designing, developing and supplying transcranial magnetic stimulation (TMS) systems to professional healthcare providers. Over 20 years ago their pioneering work started by listening to and understanding early TMS researchers. Today their product range fits the needs of innovative researchers and clinicians offering evidence-based benefit of TMS for people suffering from various neurological and psychiatric illnesses. MAG & More’s focus lies on creating innovative products which fulfil the highest quality standards. Corresponding support and training packages offer the right solution for individual customer requirements. A highly motivated team with a great deal of experience and an excellent team spirit are essential to meet the needs of international customers.